Trilogy Associates is a small firm consisting of a core team of associates with access to a larger cadre of collaborating consultants and affiliated firms with whom we have worked and whose competence we respect. Joseph Kalinowski, the founding Principal of the firm, takes a role -- often a lead role -- in every client-sponsored engagement. Our guiding principle is that a combination of sound technology grounding and preparation along with successful, multifunction business experience is essential to deliver actionable client benefits.
Our management consulting practice is made greater and broader in industry coverage through its formal affiliations, informal alliances and extensive connections with other resources. This network of professional service firms and talented individuals is exceptional, having grown and been refined over our long history.
Brief biosketches of several of our core team members follow.
Joseph J. Kalinowski
Joe Kalinowski, Principal of Trilogy Associates, founded the management consulting firm in 1989 following a 24-year career in industry building businesses with new products.
Kalinowski began his career as an engineer following his attainment of bachelor's and master's degrees in electrical engineering from Rutgers University and the University of Illinois. His career started with the Aerospace Physics Laboratory of GE's Missile and Space Division. He then joined Battelle Memorial Institute, where he executed and marketed contract research programs for numerous government and industrial clients.
Joe then joined the Corning corporate R&D organization. Over a period of 11 years, he was affiliated with Corning's medical and laboratory businesses in positions of increasing responsibilities for research, development, program management, line management, and eventually venture management for an emerging business in medical informatics for Ciba Corning Diagnostics (now Siemens Diagnostics). Kalinowski then joined Ohmeda as Director of R&D for its noninvasive monitoring business in pulse oximetry. He was later recruited to join the management team of Betagen, a young biotechnology venture in DNA blot imaging, analysis, and preparation. He served as Vice President of Development with responsibility for existing products and the formulation of new business opportunities in the creation of tools for biotechnology research.
Kalinowski took on an interim responsibility as Director of Business Development for Deknatel, a surgical devices firm, immediately following its leveraged buyout from Pfizer. At Deknatel (now part of Teleflex Medical) he identified numerous new product opportunities for growth, brought initiatives through the business planning stage, and developed external alliances for new business.
Joe has led Trilogy Associates since its formation, developing the practice and serving clients ranging in size from start-ups to Fortune-100 multinationals in industries including clinical diagnostics, laboratory and process instruments, medical and surgical devices, pharmaceuticals, patient monitoring systems, and medical informatics.
Alan M. Ganz
Alan Ganz has a technology consulting practice specializing in the development of analytical instruments. Ganz received his B.A. in physics (Summa Cum Laude, Phi Beta Kappa) from CCNY and his Ph.D. in physics from Columbia University. He began his industrial career at Exxon Production Research, where his spectroscopic studies of surfactant solutions were tied to novel ways of extracting oil. In 1987 Dr. Ganz joined the commercial side of PerkinElmer?s business in the Applied Technology Group. He was later promoted to lead an experimental unit charged with creating devices for noninvasive medical diagnostics. Reporting to the Chief Technology Officer, he performed both management functions and scientific investigations.
Since leaving PerkinElmer in 1998, Dr. Ganz has served consulting clients ranging from individual entrepreneurs to Fortune-100 companies. Having done work with institutions including Johns Hopkins Medical Center, UC Berkeley, Sarnoff Labs and Los Alamos National Laboratories, he is well connected to many of the scientific leaders in medical, materials and bioscience technologies.
Edward L. Weiner
Ed Weiner is an information and knowledge provider whose core competency is conceiving and implementing proprietary research-based investigations that fulfill clients' explicit needs. Using the insights derived from these studies, Ed counsels and supports managers who are seeking greater understanding and desire superior results. Ed's expertise is derived from extensive research and analysis experience, coupled with wide-ranging business accomplishments achieved in significant operational roles with leading technology companies worldwide. Following 16 years in industrial roles, Ed founded his consulting practice in 1983.
He specializes in obtaining vital market facts, judgments, preferences and perceptions and converting this information into applicable knowledge. Ed's practice is concentrated on the essential markets of healthcare, including diagnostics, medical information management and technology, biotechnology, medical devices, and laboratory instruments. Ed holds a B.S. degree in Chemistry from the University of Pittsburgh and an M.B.A. from Stanford University.
Edward E. Berger
A senior healthcare executive with more than 25 years of experience in medical device reimbursement analysis, planning and advocacy, Ed Berger founded his consulting practice in 2005 to help life sciences companies deal effectively with the strategic challenges and opportunities posed by the rapidly evolving healthcare regulatory and policy environment.
Building upon the knowledge and experience gained as a member of the management teams of such companies as Fresenius Medical Care, Thermo Cardiosystems, and ABIOMED, Dr. Berger has provided reimbursement analysis and strategy development consultation to a variety of clients developing new technologies in fields including mechanical circulatory support, neural monitoring and neuromodulation, gastrointestinal surgery, severe pulmonary dysfunction, nuclear medicine, diagnostic imaging, clinical laboratory testing, and personalized medicine.
Bruce A. Horwitz
Bruce supports companies trying to accelerate their intellectual property efforts, providing Director of Intellectual Property services on an outsource basis to assist small and mid-sized companies bridge the gap between technologists and their patent attorneys. His goal is for his clients to get the right patents, at the right point in the development cycle, and at the right price by providing important strategic and tactical IP management services.
Horwitz received his doctorate in Optics at the University of Rochester, after which he spent over 25 years in R&D at Litton-Itek Optical Systems and as VP of R&D for MicroE Systems. Immediately prior to founding his intellectual property practice, ., in 2000 he served as Director of Optical Technology for AXSUN Technologies.
Randall H. Morse
Randy Morse consults on technology, product, market and business issues for emerging life science companies. He has been responsible for the development and commercialization of over 30 life science products, including reagents, other consumables, analytical instruments and software. His work at startup, jump-start, private and public international life science companies has afforded him extensive hands-on experience in building infrastructure and providing leadership and guidance to a variety of enterprises.
Morse has had a distinguished industrial career in executive sales, marketing, R&D and business development roles with Schleicher & Schuell, Genetic Biosystems, PerkinElmer and Nomadics Life Sciences. Randy founded his consulting practice in 2002, concentrating on engagements dealing with due diligence, partnering, market research and strategic planning.
Kimberly F. Gruidl
Kim Gruidl is a market research and editorial consultant with special emphasis in the biomedical and chemicals sectors. Ms. Gruidl began her market research career in 1990 when she joined Teltech Network Resources as a research analyst. During her tenure at Teltech, she conducted market opportunity assessments, competitive benchmarking studies and technology evaluations for various medical products industry clients ranging from Fortune-100 multinationals to start-ups.
She holds a B.S. in chemical/biomedical engineering from the University of Minnesota and an M.A. in English from Colorado State University. Kim began her association with Trilogy Associates in 1999. In that capacity, and in her consulting practice, , she has conducted extensive market research with clinicians in healthcare-provider and research institutions and developed written materials to fulfill specific strategic and instructional objectives. She brings extraordinary capabilities in clinician interactions, strategic analysis and clear exposition.
F. Michael Hruby
Mike is a technology introduction executive. He leads a Boston-based consulting firm, ., that helps large- and mid-sized companies expand the commercial markets for their patented technologies. He researches and measures the size of new businesses that can be built around client patents, and generates first revenue for these businesses. His firm also finds prospective licensees, develops technical professional services based on product patents, and screens patent portfolios to identify promising growth platforms. Hruby has 30 years of consulting experience in technical markets and has sold and led over 500 projects.
He is the author of an award-winning book on managing technical businesses for maximum growth and shareholder value. That book, Technoleverage, was translated into German, Japanese, and Chinese. Mike has a graduate degree in Operations Research and an undergraduate degree in History.
Philip G. Drew
Phil Drew provides data and analyses to users and manufacturers of medical imaging equipment. For manufacturers and others interested in the commercial aspects of medical imaging he provides technological and market forecasts based on analysis of technical, clinical, operational and competition-related factors, as well as assistance in strategic planning, product planning and acquisition studies. He is a principal author of seven major multi-client studies, one on the outlook for the medical imaging equipment industry in the U.S. and Japan, four on the outlook for electronic medical imaging (PACS), and two on the outlook for magnetic resonance imaging. Prior to founding his consulting practice, Drew was a senior member of the staff of Arthur D. Little, Inc.
He received his B.S. in mechanical engineering from Carnegie-Mellon University; his M.S. in applied mathematics from Harvard University; and his Ph.D. in electrical engineering from Harvard. He has published over 100 articles on various aspects of medical imaging. He is a contributing editor of Diagnostic Imaging magazine and former Chairman of the Society for Computer Applications in Radiology.